vindesine has been researched along with Hodgkin Disease in 38 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 16 (42.11) | 18.7374 |
1990's | 11 (28.95) | 18.2507 |
2000's | 6 (15.79) | 29.6817 |
2010's | 5 (13.16) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Borchmann, P; Engert, A; Monsef, I; Rancea, M; Skoetz, N; Will, A | 1 |
Angrilli, F; Baldini, L; Cascavilla, N; Federico, M; Ferrari, A; Galimberti, S; Gobbi, PG; Ilariucci, F; Luminari, S; Mammi, C; Marcheselli, L; Merli, F; Musso, M; Polimeno, G; Scalzulli, PR; Stelitano, C | 1 |
Diehl, V; Evens, AM; Hutchings, M | 1 |
Kuruvilla, J | 1 |
Federico, M; Gentile, M; Gobbi, P; Hohaus, S; Iannitto, E; La Sala, A; Luminari, S; Mammi, C; Marcheselli, L; Merli, F; Montanini, A; Morabito, F; Scalone, R; Stelitano, C; Voso, MT | 1 |
Dib, M; Gagnadoux, F; Paris, A; Rousselet, MC; Tazi, A; Urban, T | 1 |
Baldini, L; Bellei, M; Bordonaro, R; Chisesi, T; Federico, M; Gobbi, P; Levis, A; Liberati, M; Luminari, S; Marcheselli, L; Merli, F; Montanini, A; Pavone, V; Pesce, EA; Stelitano, C; Vitolo, U | 1 |
Angelucci, E; Baldini, L; Bordonaro, R; Broglia, C; Cavanna, L; Chisesi, T; Deliliers, GL; Federico, M; Gobbi, PG; Levis, A; Liberati, M; Merli, F; Pavone, V; Santini, G; Stelitano, C; Vitolo, U | 1 |
Broglia, C; Cavanna, L; Chisesi, T; Corazza, GR; Corbella, F; Federico, M; Gobbi, PG; Iannitto, E; La Sala, A; Levis, A; Molica, S; Pavone, V; Sacchi, S; Valentino, F | 1 |
Amiel, JL; Ben Ayed, F; Droz, JP; Spielmann, M; Tursz, T | 1 |
Clarkson, BD; Koziner, B; Lee, BJ; Myers, J; Straus, DJ | 1 |
Arlin, Z; Gee, T; Kempin, S; Koziner, B; Lee, BJ; McCormick, B; Mertelsmann, R; Myers, J; Nisce, LZ; Straus, DJ | 1 |
Gassel, WD; Gropp, C; Havemann, K | 1 |
Aboul-Einein, M; El-Demerdash, S; El-Khoudary, A; El-Serafi, M; Gad-El-Mawla, N; Hamza, MR | 1 |
Carcassonne, Y; Gastaut, JA; Maraninchi, D; Tubiana, N | 1 |
Dölken, G; Fuchs, R; Gerhartz, H; Hagen-Aukamp, U; Hiller, E; Löffler, M; Petsch, S; Pflüger, KH; Pfreundschuh, M; Rühl, U | 2 |
Kozielski, J; Rauer, R; Spychałowicz, W; Ziora, D | 1 |
Avanzini, P; Cavanna, L; Di Renzo, N; Federico, M; Gobbi, PG; Grignani, G; Iannitto, E; Narni, F; Partesotti, G; Pieresca, C | 1 |
Diehl, V; Geilen, W; Hasenclever, D; Loeffler, M; Nisters-Backes, H; Pfreundschuh, M; Ruehl, U; Sieber, M; Smith, K; Tesch, H | 1 |
Kumagai, K; Sakai, C; Takagi, T; Wakatsuki, S | 1 |
Abella, E; Al-Katib, A; Heilbrun, LK; Karanes, C; Kasten-Sportes, C; Lum, L; Momin, F; Ratanatharathorn, V; Uberti, JP; Varterasian, M | 1 |
André, M; Brice, P; Cazals, D; Fermé, C; Gisselbrecht, C; Hennequin, C; Kerneis, Y; Lepage, E; Rousselot, P; Zini, JM | 1 |
Bibi Triki, T; Brice, P; Fermé, C; Fitoussi, O; Gisselbrecht, C; Hennequin, C; Makke, J; Scrobohaci, ML; Simon, D | 1 |
Angrilli, F; Ascari, E; Bertè, R; Broglia, C; Cavanna, L; Di Renzo, N; Ghirardelli, ML; Gobbi, PG; Iannitto, E; Molica, S; Petrilli, MP | 1 |
André, M; Berger, F; Bosly, A; Brière, J; Cazals-Hatem, D; Copin, MC; Diebold, J; Divine, M; Gaulard, P; Kerneis, Y; Mounier, N; Quesnel, B | 1 |
Cooper, I; Dodds, AJ; Downs, K; Januszewicz, H; Ma, D; Morgan, MJ; Wolf, M | 1 |
Caravelli, J; Chapman, D; Clarkson, BD; Gaynor, JJ; Merke, DP; Myers, J; Straus, DJ; Yahalom, J | 1 |
Diehl, V; Georgii, A; Gerhartz, H; Hiller, E; Löffler, M; Pfreundschuh, M; Rühl, U; Smith, K | 1 |
Koziner, B; Zori Comba, A | 1 |
Diehl, V; Fuchs, R; Loeffler, M; Pflüger, KH; Pfreundschuh, MG; Schoppe, WD | 1 |
Straus, DJ | 1 |
Caravelli, J; Chapman, D; Clarkson, BD; Gaynor, J; Lee, BJ; Merke, D; Myers, J; Nisce, LZ; Straus, DJ | 1 |
Anselmi, A; Carella, AM; Carlier, P; Cimino, G; Congiu, A; Mangoni, L; Mazza, P; Meloni, G; Porcellini, A | 1 |
Kosaka, M; Matsumoto, N; Okagawa, K; Saito, S; Yoshimoto, K | 1 |
Jurd, J; Vincent, PC; Young, GA | 1 |
4 review(s) available for vindesine and Hodgkin Disease
Article | Year |
---|---|
Treatment of Hodgkin lymphoma: the past, present, and future.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials, Phase III as Topic; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Lomustine; Mechlorethamine; Melphalan; Multicenter Studies as Topic; Neoplasm Staging; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Vinblastine; Vincristine; Vindesine | 2008 |
Standard therapy of advanced Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Mechlorethamine; Melphalan; Methylprednisolone; Positron-Emission Tomography; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Salvage Therapy; Transplantation, Autologous; Treatment Outcome; Vinblastine; Vincristine; Vindesine | 2009 |
[Rescue treatment in Hodgkin's disease].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Lomustine; Mechlorethamine; Melphalan; Prednisone; Procarbazine; Vinblastine; Vincristine; Vindesine | 1987 |
Treatment of advanced Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Leukemia; Lomustine; Lymphoma; Male; Mechlorethamine; Melphalan; Middle Aged; Neoplasms, Multiple Primary; Prednisone; Procarbazine; Remission Induction; Vinblastine; Vincristine; Vindesine | 1989 |
20 trial(s) available for vindesine and Hodgkin Disease
Article | Year |
---|---|
Long-Term Results of the HD2000 Trial Comparing ABVD Versus BEACOPP Versus COPP-EBV-CAD in Untreated Patients With Advanced Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Epirubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Incidence; Italy; Kaplan-Meier Estimate; Lomustine; Male; Melphalan; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Treatment Outcome; Vinblastine; Vincristine; Vindesine | 2016 |
Role of glutathione-S-transferase (GST) polymorphisms in patients with advanced Hodgkin lymphoma: results from the HD2000 GISL trial.
Topics: Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Biotransformation; Bleomycin; Carboplatin; Cyclophosphamide; Dacarbazine; Doxorubicin; Epirubicin; Etoposide; Female; Gene Deletion; Genetic Predisposition to Disease; Genotype; Glutathione S-Transferase pi; Glutathione Transferase; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; Neoplasm Proteins; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Prednisone; Procarbazine; Prognosis; Treatment Outcome; Vinblastine; Vincristine; Vindesine | 2012 |
Long-term follow-up analysis of HD9601 trial comparing ABVD versus Stanford V versus MOPP/EBV/CAD in patients with newly diagnosed advanced-stage Hodgkin's lymphoma: a study from the Intergruppo Italiano Linfomi.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Vinblastine; Vincristine; Vindesine | 2011 |
ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Melphalan; Middle Aged; Prednisone; Procarbazine; Treatment Outcome; Vinblastine; Vincristine; Vindesine | 2005 |
MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Drug-Related Side Effects and Adverse Reactions; Epirubicin; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Neoplasms, Second Primary; Pilot Projects; Prednisone; Procarbazine; Survival Rate; Treatment Outcome; Vinblastine; Vincristine; Vindesine | 2006 |
[Salvage chemotherapy in resistant malignant lymphomas (author's transl)].
Topics: Adolescent; Adult; Bleomycin; Cisplatin; Clinical Trials as Topic; Dacarbazine; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma; Male; Middle Aged; Neoplasm Staging; Vinblastine; Vindesine | 1982 |
Treatment of advanced Hodgkin's disease with chemotherapy and irradiation. Controlled trial of two versus three alternating, potentially non-cross-resistant drug combinations.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Melphalan; Middle Aged; Prednisone; Procarbazine; Vinblastine; Vincristine; Vindesine | 1984 |
Prognosis of high dose chemotherapy/autologous bone marrow transplantation candidates not receiving this treatment after failure of primary therapy of Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Life Tables; Lomustine; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Procarbazine; Prognosis; Prospective Studies; Remission Induction; Risk Factors; Salvage Therapy; Survival Analysis; Survival Rate; Treatment Failure; Vinblastine; Vincristine; Vindesine | 1994 |
Further chemotherapy versus low-dose involved-field radiotherapy as consolidation of complete remission after six cycles of alternating chemotherapy in patients with advance Hodgkin's disease. German Hodgkins' Study Group (GHSG).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Lomustine; Middle Aged; Prednisone; Procarbazine; Prognosis; Prospective Studies; Radiotherapy Dosage; Remission Induction; Survival Rate; Treatment Failure; Treatment Outcome; Vinblastine; Vincristine; Vindesine | 1995 |
[Alternating chemotherapy with cyclophosphamide, adriamycin, vincristine and prednisolone (CHOP); etoposide, procarbazine, vindesine and prednisolone (EPVP) as a treatment for advanced-stage Hodgkin's disease].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Pilot Projects; Prednisolone; Procarbazine; Remission Induction; Vincristine; Vindesine | 1996 |
Results of three courses of adriamycin, bleomycin, vindesine, and dacarbazine with subtotal nodal irradiation in 189 patients with nodal Hodgkin's disease (stage I, II and IIIA).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Gonads; Heart; Hodgkin Disease; Humans; Lung; Male; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prospective Studies; Radiotherapy; Survival Rate; Thyroid Gland; Treatment Outcome; Vinblastine; Vindesine | 1997 |
Lomustine and melphalan cannot be replaced by cyclophosphamide and etoposide without reducing efficacy in MOPPEBVCAD chemotherapy for advanced Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Epirubicin; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Melphalan; Middle Aged; Prednisone; Procarbazine; Prospective Studies; Treatment Outcome; Vinblastine; Vincristine; Vindesine | 2000 |
[Recurrence of Hodgkin's disease after advanced primary stages. German Hodgkin's Study Group].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dexamethasone; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Procarbazine; Survival Rate; Vinblastine; Vincristine; Vindesine | 1992 |
High dose chemotherapy and autologous bone marrow transplantation in advanced Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Cisplatin; Combined Modality Therapy; Drug Resistance; Female; Hodgkin Disease; Humans; Male; Middle Aged; Prospective Studies; Remission Induction; Salvage Therapy; Survival Rate; Treatment Outcome; Vindesine | 1992 |
Prognostic factors among 185 adults with newly diagnosed advanced Hodgkin's disease treated with alternating potentially noncross-resistant chemotherapy and intermediate-dose radiation therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hematocrit; Hodgkin Disease; Humans; Lomustine; Lymphatic Metastasis; Male; Mechlorethamine; Melphalan; Middle Aged; Models, Biological; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Remission Induction; Survival Analysis; Vinblastine; Vincristine; Vindesine | 1990 |
[Intermediate results of the German Hodgkin's disease therapy study].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Germany, West; Hodgkin Disease; Humans; Lomustine; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Radiotherapy Dosage; Vinblastine; Vincristine; Vindesine | 1986 |
[Therapy studies of the German Hodgkin's Study Group. Intermediate results of the study protocols HD1, HD2, and HD3].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Lomustine; Neoplasm Staging; Pilot Projects; Prednisone; Procarbazine; Prognosis; Vinblastine; Vincristine; Vindesine | 1987 |
Treatment of advanced Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Leukemia; Lomustine; Lymphoma; Male; Mechlorethamine; Melphalan; Middle Aged; Neoplasms, Multiple Primary; Prednisone; Procarbazine; Remission Induction; Vinblastine; Vincristine; Vindesine | 1989 |
Results and prognostic factors following optimal treatment of advanced Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Lomustine; Mechlorethamine; Melphalan; Middle Aged; Prednisone; Procarbazine; Randomized Controlled Trials as Topic; Vinblastine; Vincristine; Vindesine | 1989 |
Italian experience with autologous bone marrow transplantation in 104 advanced Hodgkin's lymphoma patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Cisplatin; Clinical Trials as Topic; Hodgkin Disease; Humans; Infections; Transplantation, Autologous; Vindesine | 1989 |
15 other study(ies) available for vindesine and Hodgkin Disease
Article | Year |
---|---|
Fifteenth biannual report of the Cochrane Haematological Malignancies Group--focus on non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bleomycin; Cyclophosphamide; Dasatinib; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphoma, Non-Hodgkin; Middle Aged; Multicenter Studies as Topic; Multiple Myeloma; Neoplasm Staging; Piperazines; Platelet Transfusion; Prednisone; Primary Prevention; Procarbazine; Pyrimidines; Randomized Controlled Trials as Topic; Rituximab; Stem Cell Transplantation; Survival Analysis; Thiazoles; Thrombocytopenia; Transplantation, Autologous; Treatment Outcome; Vincristine; Vindesine | 2013 |
[Pulmonary Langerhans histiocytosis and Hodgkin's lymphoma].
Topics: Accidents, Traffic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bronchioles; Carmustine; Cytarabine; Dacarbazine; Doxorubicin; Etoposide; Female; Histiocytosis, Langerhans-Cell; Hodgkin Disease; Humans; Ifosfamide; Incidental Findings; Lung Diseases; Lymphatic Diseases; Marijuana Smoking; Melphalan; Methylprednisolone; Mitoguazone; Remission Induction; Smoking; Tomography, X-Ray Computed; Vinblastine; Vindesine; Vinorelbine; Young Adult | 2011 |
Combination chemotherapy for the treatment of Hodgkin's disease in relapse. Results with lomustine (CCNU), melphalan (Alkeran), and vindesine (DVA) alone (CAD) and in alternation with MOPP and doxorubicin (Adriamycin), bleomycin, and vinblastine (ABV).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Melphalan; Middle Aged; Prednisone; Procarbazine; Vinblastine; Vincristine; Vindesine | 1983 |
Acute allergic reaction due to vincristine sulfate. A case report.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Drug Hypersensitivity; Hodgkin Disease; Humans; Male; Mechlorethamine; Prednisone; Procarbazine; Vinblastine; Vincristine; Vindesine | 1984 |
[Phase II study of vindesine in hematological malignancies].
Topics: Adult; Child; Drug Evaluation; Hodgkin Disease; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma; Vinblastine; Vindesine | 1983 |
Phase II study of vindesine in patients with Hodgkin's disease, lymphoma, and breast cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Drug Evaluation; Hodgkin Disease; Humans; Vinblastine; Vindesine | 1983 |
[Continuous 5-day vindesine in the treatment of leukemias and lymphomas (author's transl)].
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Female; Hodgkin Disease; Humans; Infusions, Parenteral; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Vinblastine; Vindesine | 1981 |
[Lung fibrosis after bleomycin therapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Hodgkin Disease; Humans; Lung Neoplasms; Male; Mechlorethamine; Prednisone; Procarbazine; Pulmonary Fibrosis; Vincristine; Vindesine | 1994 |
MOPP/EBV/CAD hybrid chemotherapy with or without limited radiotherapy in advanced or unfavorably presenting Hodgkin's disease: a report from the Italian Lymphoma Study Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Survival Rate; Vinblastine; Vincristine; Vindesine | 1993 |
Clinical course and outcome of patients with Hodgkin's disease who progress after autologous transplantation.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Cisplatin; Combined Modality Therapy; Disease Progression; Disease-Free Survival; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Retrospective Studies; Survival Rate; Transplantation, Autologous; Treatment Outcome; Vindesine; Whole-Body Irradiation | 1995 |
Tandem transplant of peripheral blood stem cells for patients with poor-prognosis Hodgkins's disease or non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisolone; Prognosis; Salvage Therapy; Transplantation Conditioning; Venous Thrombosis; Vindesine | 1999 |
Pathologic and clinical features of 77 Hodgkin's lymphoma patients treated in a lymphoma protocol (LNH87): a GELA study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Female; Hodgkin Disease; Humans; Immunoenzyme Techniques; Immunophenotyping; Lymphoma, Large-Cell, Anaplastic; Male; Middle Aged; Neoplasm Proteins; Prednisone; Survival Rate; Treatment Outcome; Vindesine | 2001 |
Lomustine, etoposide, vindesine, and dexamethasone (CEVD) in Hodgkin's lymphoma refractory to cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) and doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD): a multicenter trial of the Ge
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Dexamethasone; Doxorubicin; Drug Resistance; Etoposide; Hodgkin Disease; Humans; Lomustine; Middle Aged; Multi-Institutional Systems; Prednisone; Procarbazine; Vinblastine; Vincristine; Vindesine | 1987 |
[A case of Hodgkin's disease exhibiting erythrodermia probably due to allergic reaction to vinca alkaloids].
Topics: Antineoplastic Combined Chemotherapy Protocols; Dermatitis, Exfoliative; Drug Eruptions; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Vincristine; Vindesine | 1989 |
Vindesine in the treatment of refractory haematological malignant diseases.
Topics: Adolescent; Adult; Aged; Female; Hematologic Diseases; Hodgkin Disease; Humans; Leukemia; Lymphoma; Male; Middle Aged; Vinblastine; Vindesine | 1985 |